A decade of exploring the cancer epigenome - biological and translational implications

被引:2069
作者
Baylin, Stephen B. [1 ]
Jones, Peter A. [2 ]
机构
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
[2] Univ So Calif, USC Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITION; METHYLTRANSFERASE GENE EZH2; DNA METHYLATION PATTERNS; TUMOR-SUPPRESSOR GENES; CPG-ISLAND METHYLATION; EMBRYONIC STEM-CELLS; COLORECTAL-CANCER; PROSTATE-CANCER; MYELODYSPLASTIC SYNDROMES;
D O I
10.1038/nrc3130
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The past decade has highlighted the central role of epigenetic processes in cancer causation, progression and treatment. Next-generation sequencing is providing a window for visualizing the human epigenome and how it is altered in cancer. This view provides many surprises, including linking epigenetic abnormalities to mutations in genes that control DNA methylation, the packaging and the function of DNA in chromatin, and metabolism. Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis. The enzymatic processes that control the epigenome present new opportunities for deriving therapeutic strategies designed to reverse transcriptional abnormalities that are inherent to the cancer epigenome.
引用
收藏
页码:726 / 734
页数:9
相关论文
共 166 条
[1]   The emerging functions of histone demethylases [J].
Agger, Karl ;
Christensen, Jesper ;
Cloos, Paul A. C. ;
Helin, Kristian .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (02) :159-168
[2]   GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer [J].
Akiyama, Y ;
Watkins, N ;
Suzuki, H ;
Jair, KW ;
van Engeland, M ;
Esteller, M ;
Sakai, H ;
Ren, CY ;
Yuasa, Y ;
Herman, JG ;
Baylin, SB .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (23) :8429-8439
[3]  
ALLIS CD, 2007, OVERVIEW CONCEPTS
[4]   Chromatin signatures of pluripotent cell lines [J].
Azuara, V ;
Perry, P ;
Sauer, S ;
Spivakov, M ;
Jorgensen, HF ;
John, RM ;
Gouti, M ;
Casanova, M ;
Warnes, G ;
Merkenschlager, M ;
Fisher, AG .
NATURE CELL BIOLOGY, 2006, 8 (05) :532-U189
[5]   MS-qFRET: A quantum dot-based method for analysis of DNA methylation [J].
Bailey, Vasudev J. ;
Easwaran, Hariharan ;
Zhang, Yi ;
Griffiths, Elizabeth ;
Belinsky, Steven A. ;
Herman, James G. ;
Baylin, Stephen B. ;
Carraway, Hetty E. ;
Wang, Tza-Huei .
GENOME RESEARCH, 2009, 19 (08) :1455-1461
[6]   SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation [J].
Banine, F ;
Bartlett, C ;
Gunawardena, R ;
Muchardt, C ;
Yaniv, M ;
Knudsen, ES ;
Weissman, BE ;
Sherman, LS .
CANCER RESEARCH, 2005, 65 (09) :3542-3547
[7]   Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations [J].
Barekati, Zeinab ;
Radpour, Ramin ;
Kohler, Corina ;
Zhang, Bei ;
Toniolo, Paolo ;
Lenner, Per ;
Lv, Qing ;
Zheng, Hong ;
Zhong, Xiao Yan .
HUMAN MOLECULAR GENETICS, 2010, 19 (15) :2936-2946
[8]   Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation [J].
Bartke, Till ;
Vermeulen, Michiel ;
Xhemalce, Blerta ;
Robson, Samuel C. ;
Mann, Matthias ;
Kouzarides, Tony .
CELL, 2010, 143 (03) :470-484
[9]  
BAYLIN SB, 2009, STEMBOOK, P2
[10]   Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene [J].
Bell, AC ;
Felsenfeld, G .
NATURE, 2000, 405 (6785) :482-485